| 产品名称 | Golvatinib - E 7050 |
| 产品货号 | Axon 1959 CAS [928037-13-2] MF C33H37F2N7O4MW 633.69 Purity: 99% Soluble in 0.1N HCl(aq) and DMSO Description Potent and orally available inhibitor of c-MET (HGFR) (IC50: 14 nM) and VEGFR2 (IC50: 16 nM); Golvatinib inhibits the activities of both c-Met and VEGFR2, which may inhibit tumor cell growth and survival of tumor cells that overexpress these receptor tyrosine kinases References Certificates Categories Extra info T Nakagawa et al. E7050: A dual c-Met and VEGFR-2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models. Cancer Science 2010, 101(1), 210-215. W Wang et al. Met kinase inhibitor E7050 reverses three different mechanisms of hepatocyte growth factor-induced tyrosine kinase inhibitor resistance in EGFR mutant lung cancer. Clin Cancer Res. 2012, 18(6):1663-1671. Certificate of Analysis Material Safety Data Sheet Angiogenesis Cell Signaling & Oncology c-MET VEGFR RTK class IV and X; EC 2.7.10.1 Potent and orally available inhibitor of c-MET (HGFR) and VEGFR2 Chemical name N-(2-fluoro-4-(2-(4-(4-methylpiperazin-1-yl)piperidine-1-carboxamido)pyridin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Parent CAS No. [928037-13-2] Order Size Unit Price Stock 10 mg €95.00 In Stock |
| 产品价格 | 现货询价，电话：010-67529703 |
| 产品规格 | |
| 产品品牌 | axonmedchem |
| 产品概述 | |
| 产品详情 |
Golvatinib - E 7050Axon 1959 CAS [928037-13-2] MF C33H37F2N7O4
Description
Potent and orally available inhibitor of c-MET (HGFR) (IC50: 14 nM) and VEGFR2 (IC50: 16 nM); Golvatinib inhibits the activities of both c-Met and VEGFR2, which may inhibit tumor cell growth and survival of tumor cells that overexpress these receptor tyrosine kinases
Potent and orally available inhibitor of c-MET (HGFR) and VEGFR2
Chemical nameN-(2-fluoro-4-(2-(4-(4-methylpiperazin-1-yl)piperidine-1-carboxamido)pyridin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Parent CAS No.[928037-13-2] |
| 产品资料 |
